NCT04395976 is a NA clinical trial of Ayurveda in Covid-19, sponsored by British Ayurvedic Medical Council.

Who is sponsoring NCT04395976?

NCT04395976 is sponsored by British Ayurvedic Medical Council.

What drugs are being tested in NCT04395976?

Interventions in NCT04395976: Ayurveda.

Is NCT04395976 still recruiting?

NCT04395976 is currently withdrawn. Last updated 2 March 2021.

Last reviewed 2021-03-02 · How we verify

NCT04395976

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ayurveda as Prophylaxis for Suspected COVID-19 Patients

Withdrawn NA Last updated 2 March 2021

What this trial tests

NA trial testing Ayurveda in Covid-19. Withdrawn.

Timeline

10 May 2020

Primary endpoint
10 June 2020

1 September 2020

Quick facts

Lead sponsor	British Ayurvedic Medical Council
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Start date	10 May 2020
Primary completion	10 June 2020
Estimated completion	1 September 2020
Sites	1 location across United Kingdom

Drugs / interventions tested

Ayurveda

Conditions studied

Covid-19 — all drugs for Covid-19 →

Sponsor

British Ayurvedic Medical Council

Who can join

18 and older, any sex, with Covid-19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Despite worldwide efforts to contain, manage and treat Covid-19, the pandemic is continuing to spread. This calls for an urgent clinically-proven prophylaxis and therapeutic strategy. Recent developments on the use of traditional medicines in Covid-19 management has drawn enough attention to start several research studies. Based on the Indian Traditional Medicine, Ayurveda's community initiatives, preliminary studies, and our experiential knowledge on Covid-19 settings, we propose present study to prevent the development of COVID-19 symptoms in people who live or have come contact with an individual diagnosed with COVID-19.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Promising traditional Indian medicinal plants for the management of novel Coronavirus disease: A systematic review.
Singh RS, Singh A, Kaur H, Batra G, et al · · 2021 · cited 22× · PMID 34132429 · DOI 10.1002/ptr.7150
A Comprehensive Summary of the Knowledge on COVID-19 Treatment.
Peng Y, Tao H, Satyanarayanan SK, Jin K, et al · · 2021 · cited 18× · PMID 33532135 · DOI 10.14336/ad.2020.1124
An exhaustive comprehension of the role of herbal medicines in Pre- and Post-COVID manifestations.
Prajapati SK, Malaiya A, Mishra G, Jain D, et al · · 2022 · cited 11× · PMID 35654349 · DOI 10.1016/j.jep.2022.115420
COVID-19: Recent Insight in Genomic Feature, Pathogenesis, Immunological Biomarkers, Treatment Options and Clinical Updates on SARS-CoV-2.
Deshmukh R, Harwansh RK, Garg A, Mishra S, et al · · 2024 · cited 5× · PMID 38751601 · DOI 10.2174/0113892029291098240129113500

Verify or expand the search:

Other trials of Ayurveda

Trials testing the same drug.

NCT04716647 — Feasibility of Ayurveda in Patients With Mild-to-Moderate COVID-19: A Community-Based Participatory Research · NA · completed
NCT04351542 — Ayurveda for Flu Like Illness During Covid-19 Outbreak · NA · completed

Other recruiting trials for Covid-19

Currently open trials in the same condition.

NCT05943743 — Hiccups and Obstacles Of E-Learning Among Medical Sudents · recruiting
NCT04466683 — Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia · Phase 2 · active not recruiting
NCT04433364 — COPE - COVID-19 in Pregnancy and Early Childhood · active not recruiting
NCT04568148 — COVID-19 Biorepository · active not recruiting
NCT04360538 — Long Term Outcomes of Patients With COVID-19 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04395976 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by British Ayurvedic Medical Council
Last refreshed: 2 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04395976.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing